Insulet (NASDAQ: PODD) net income
Insulet reported a net profit of $247.1m for fiscal 2025, 40.9% less than in fiscal 2024 ($418.3m). Its net margin was 9.1%. Earnings per share were $3.51.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $247.1m | −40.9% | 9.1% | $3.51 |
| 2024 | $418.3m | +102.8% | 20.2% | $5.97 |
| 2023 | $206.3m | +4,384.8% | 12.2% | $2.96 |
| 2022 | $4.6m | −72.6% | 0.4% | $0.07 |
| 2021 | $16.8m | +147.1% | 1.5% | $0.25 |
| 2020 | $6.8m | −41.4% | 0.8% | $0.11 |
| 2019 | $11.6m | +251.5% | 1.6% | $0.19 |
| 2018 | $3.3m | — | 0.6% | $0.06 |
| 2017 | −$26.8m | — | −5.8% | −$0.46 |
| 2016 | −$28.9m | — | −7.9% | −$0.48 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the net income of Insulet
- How much did Insulet earn in fiscal 2025?
- Insulet reported a net profit of $247.1m for fiscal 2025. In fiscal 2024 it reported a net profit of $418.3m.
- What are the earnings per share of Insulet?
- They were $3.51 in fiscal 2025, compared with $5.97 in fiscal 2024.
- What is the net margin of Insulet?
- In fiscal 2025 its net profit was 9.1% of its revenue.
- What was the most profitable year for Insulet?
- Of its last 10 fiscal years, fiscal 2024, with $418.3m.
- Where do the figures for Insulet come from?
- From the annual report (Form 10-K) that Insulet files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Insulet files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Insulet: the Insulet page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.